Public health officials said more than 233,000 bottles of an antidepressant have been recalled due to a chemical that contains the risk of cancer.
The U.S. Food and Drug Administration (FDA) classified capsules of duloxetine as a Class II risk on Dec. 5, USA TODAY reports.
New Jersey-based company Rising Pharmaceuticals sells
Continue reading

Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!